Back
Science

Study Links Dietary Melatonin Patterns to Lower Obesity and Depression Rates

Generated on: Last updated: 1 sources
View source

Dietary Melatonin: Uncovering Its Link to Obesity and Depression

A recent study delved into the melatonin content of everyday foods and explored its potential relationship with chronic diseases, shedding light on how our diet might influence health outcomes.

Background: Melatonin Beyond Supplements

Melatonin, a hormone found naturally in both animal and plant-based foods, has been associated with various health benefits, including improvements in sleep, mood, and metabolic health. While food sources offer lower concentrations compared to supplements, a melatonin-rich diet can still elevate circulating levels within physiological ranges. This dietary approach is thought to provide doses that align with the body's natural rhythms, potentially avoiding the suprapharmacological exposure often linked with supplements.

Rationale: Dietary Melatonin as a Lifestyle Marker

Given the widespread prevalence of conditions like obesity, depression, and sleep disorders, researchers investigated dietary melatonin not as a direct treatment, but as a potential marker for dietary patterns connected to these conditions.

Dietary melatonin was examined as a potential marker for dietary patterns associated with chronic conditions, rather than as a direct therapeutic agent.

Previous research has hinted at melatonin's protective effects against inflammatory, metabolic, and neurobehavioral issues, with some observational studies reporting inverse associations with liver cancer and all-cause mortality. However, direct examination of habitual dietary melatonin intake and its links to chronic conditions in adults has remained limited until now.

Study Design and Participants

Researchers analyzed melatonin concentrations across 119 food items and investigated their association with various health outcomes. The study participants were drawn from the Cohort of Universities of Minas Gerais (CUME+) study, an ongoing prospective cohort focused on diet's impact on noncommunicable diseases.

The baseline data included 8,320 participants, with a mean age of 35.9 years. The majority were female and non-smokers. The most commonly reported health conditions among participants included dyslipidemia, depression, obesity, and hypertension.

Methodology: Tracking Diet and Health

Participants completed a comprehensive two-part questionnaire covering sociodemographics, clinical history, lifestyle, anthropometrics, morbidity, dietary habits, supplement use, and cooking practices. A food frequency questionnaire (FFQ) was utilized to determine nutrient intake, and dietary melatonin content was estimated from existing literature, then adjusted for total energy intake.

Health outcomes analyzed included:

  • Obesity (BMI ≥ 30 kg/m²)
  • Obstructive sleep apnea (OSA)
  • Hypertension
  • Metabolic syndrome (MetS)
  • Type 2 diabetes (T2D)
  • Sleep duration
  • Dyslipidemia
  • Depression

Statistical analysis employed logistic and Poisson regression models, with adjustments for age, sex, income, binge drinking, smoking, screen time, physical activity, medication use, and sleep duration to ensure robust findings.

Key Findings: Linking Melatonin to Obesity and Depression

The study yielded several significant insights into dietary melatonin intake:

  • Melatonin content in the 119 food items ranged from 0 to 169.9 ng/g.
  • The average daily melatonin intake was 25,554.7 ng, with males generally showing higher intake than females.
  • Coffee, lentils and beans, and rice were identified as the primary dietary sources of melatonin.
  • Higher melatonin intake correlated with lower consumption of protein, cholesterol, and saturated and monounsaturated fats, alongside higher intake of fiber and carbohydrates.
  • No significant associations were observed between dietary melatonin intake and OSA, hypertension, MetS, or T2D.
  • Initial associations with sleep duration and dyslipidemia lost statistical significance after adjusting for age and sex.
  • An inverse association was found between dietary melatonin intake and both obesity and depression.

Individuals with daily melatonin intakes in intermediate ranges showed the strongest reduced likelihood of obesity and depression.

Specifically, participants with daily melatonin intakes in intermediate ranges (14,900 to 34,400 ng for obesity; 14,900 to 25,000 ng for depression) showed the strongest reduced likelihood of these conditions.

Conclusion: A Role in Metabolic and Neurobehavioral Regulation

The study suggests an inverse relationship between dietary melatonin intake and the incidence of depression and obesity within the studied population. These findings support the hypothesis that dietary melatonin may play a role in metabolic and neurobehavioral regulation, potentially through anti-inflammatory pathways.

The cross-sectional nature of the study prevents the establishment of causal links, necessitating further experimental and longitudinal research to confirm these associations and elucidate underlying mechanisms.